Research

Development of a continuous flow reactor for pharmaceuticals using catalytic monoliths:Pt/C selective oxidation of benzyl alcohol


Reference:

Al Badran, F., Awdry, S. and Kolaczkowski, S.T., 2013. Development of a continuous flow reactor for pharmaceuticals using catalytic monoliths:Pt/C selective oxidation of benzyl alcohol. Catalysis Today, 216, pp. 229-239.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below. (Contact Author)

Official URL:

http://dx.doi.org/10.1016/j.cattod.2013.04.017

Related URLs:

Abstract

A novel design of pilot-scale continuous flow pharmaceutical fixed-bed catalytic reactor has been developed. This incorporates in a structured manner the use of multiple catalytic monoliths (o.d. = 20 mm; L = 50 mm). O2 was used as the oxidant (O2/N2 mixture) for the partial oxidation of benzyl alcohol to benzaldehyde, using Pt impregnated (2.5 and 2.7 wt%) carbon monoliths. Reactions were performed e.g. at liquid flow = 1 dm 3 h-1; benzyl alcohol concentration = 1 kmol m -3; T = 110 C; P = 12 bar(g). A major breakthrough was the demonstration of the viability of this design at pilot-scale.

Details

Item Type Articles
CreatorsAl Badran, F., Awdry, S. and Kolaczkowski, S.T.
DOI10.1016/j.cattod.2013.04.017
Related URLs
URLURL Type
http://www.scopus.com/inward/record.url?scp=84883742121&partnerID=8YFLogxKUNSPECIFIED
DepartmentsFaculty of Engineering & Design > Chemical Engineering
Research CentresCentre for Sustainable Chemical Technologies
RefereedYes
StatusPublished
ID Code37116

Export

Actions (login required)

View Item